This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Nissan Chemical Corporation, Peptidream Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2024
Title: Naohiko Yasuda: Innovator in Peptide Production
Introduction
Naohiko Yasuda is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of peptide chemistry, particularly through his innovative methods for producing peptide compounds. His work has implications in various scientific and medical applications.
Latest Patents
Yasuda holds a patent for a method for producing peptide compounds. This invention outlines a two-step process that includes condensing a C-protected amino acid or peptide to the C-terminal of an N-protected amino acid or peptide. The method also involves removing the protective group at the C-terminal of the resulting peptide. This patent showcases his expertise in peptide synthesis and highlights the potential for advancements in biochemistry.
Career Highlights
Throughout his career, Yasuda has worked with prominent companies such as Nissan Chemical Corporation and Peptidream Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in peptide production.
Collaborations
Yasuda has collaborated with esteemed colleagues, including Michiharu Handa and Akihiro Nagaya. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Naohiko Yasuda's contributions to peptide chemistry through his patented methods demonstrate his role as a significant inventor in the field. His work continues to influence advancements in biochemistry and related disciplines.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile